RT Journal Article
SR Electronic
T1 Predictive Modelling of COVID-19 New Cases in Algeria using An Extreme Learning Machines (ELM)
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.28.20203299
DO 10.1101/2020.09.28.20203299
A1 Messaoud Djeddou
A1 Ibrahim A. Hameed
A1 Abolfazl Nejatian
A1 Imed Loukam
YR 2020
UL http://medrxiv.org/content/early/2020/09/29/2020.09.28.20203299.abstract
AB In this research, an extreme learning machine (ELM) is proposed to predict the new COVID-19 cases in Algeria. In the present study, public health database from Algeria health ministry has been used to train and test the ELM models.The input parameters for the predictive models include Cumulative Confirmed COVID-19 Cases (CCCC), Calculated COVID-19 New Cases (CCNC), and Index Day (ID).The predictive accuracy of the seven models has been assessed via several statistical parameters. The results showed that the proposed ELM model achieved an adequate level of prediction accuracy with smallest errors (MSE= 0.16, RMSE=0.4114, and MAE= 0.2912), and highest performance’s (NSE = 0.9999, IO = 0.9988, R2 = 0.9999). Hence, the ELM model could be utilized as a reliable and accurate modeling approach for predicting the new COVIS-19 cases in Algeria.The proposed ELM model, it can be used as a decision support tool to manage public health medical efforts and facilities against the COVID-19 pandemic crisis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No provided approval was needed for this research.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data used in this research was was donwloaded from the web site: https://en.wikipedia.org/wiki/COVID-19_pandemic_in_Algeria